Synapse - Hematology-Oncology Fellows

Results (254)

Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

Meeting Abstract

Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma

Meeting Abstract

Firestone, R.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Patel, D.; Tan, C. R.; Hultcrantz, M.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers

Journal Article

Jiagge, E.; Jin, D. X.; Newberg, J. Y.; Perea-Chamblee, T.; Pekala, K. R.; Fong, C.; Waters, M.; Ma, D.; Dei-Adomakoh, Y.; Erb, G.; more...
Cancer Cell (2023)

Fulltext@MSK | Save

Allogeneic CAR T cells with regulated NEF expression display immune evasion and optimized signaling

Meeting Abstract

Perica, K.; Mansilla-Soto, J.; Kotchetkov, I.; Sadelain, M.
Molecular Therapy (2023)

Fulltext@MSK | Save

Institutional experience of routine genomic profiling of cell-free DNA from cerebrospinal fluid across a wide range of malignancies

Meeting Abstract

Hickman, R.; Miller, A.; Jee, J.; Liu, S.; Pentsova, E.; Holle, B.; Ross, D.; Nandakumar, S.; Vanderbilt, C.; Rana, S.; more...
Journal of Neuropathology and Experimental Neurology (2023)

Fulltext@MSK | Save

Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry

Meeting Abstract

Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Real-world landscape analysis of activating ERBB2/ERBB3 alterations in 107,561 tissue and plasma samples from patients with NSCLC

Meeting Abstract

Liu, D.; Jee, J.; Keller, R. B.; Schrock, A. B.; Drilon, A.; Oxnard, G. R.; Li, B. T.
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade

Journal Article

Harrold, E. C.; Foote, M. B.; Rousseau, B.; Walch, H.; Kemel, Y.; Richards, A. L.; Keane, F.; Cercek, A.; Yaeger, R.; Rathkopf, D.; more...
Nature Medicine (2023)

Fulltext@MSK | Save

AI serial image prediction of progression-free survival (PFS) for locally advanced non-small cell lung cancer (LA-NSCLC) patients treated with chemoradiation (CRT) and durvalumab consolidation

Meeting Abstract

Veeraraghavan, H.; Jiang, J.; Jee, J.; Lebow, E. S.; Deasy, J. O.; Rimner, A.; Shaverdian, N.; Yu, H.; Gomez, D. R.
International Journal of Radiation Oncology, Biology, Physics (2023)

Fulltext@MSK | Save

KRAS(G12D) inhibition in pancreatic cancer: Fas expression facilitates immune clearance

Editorial

Yeh, C.; Park, W.; Yaeger, R.
Developmental Cell (2023)

Fulltext@MSK | Save